guide to successful bioprospecting: informed by actinobacterial systematics

• Published in: Antonie van Leeuwenhoek Vol. 98; no. 2; pp. 119 - 142
• Main Authors: Goodfellow, Michael, Fiedler, Hans-Peter
• Format: Journal Article Conference Proceeding
• Language: English
• Published: Dordrecht Dordrecht : Springer Netherlands 01.08.2010; Springer Netherlands; Springer; Springer Nature B.V
• Subjects: Actinobacteria; Actinomycetales; Actinomycetales - classification; Actinomycetales - genetics; Actinomycetales - isolation & purification; Actinomycetales - metabolism; antibiotics; Bacteria; Bacteriology; Bioactive compounds; Biological and medical sciences; Biological products; Biomedical and Life Sciences; Bioprospecting; Bridged Bicyclo Compounds, Heterocyclic; Bridged Bicyclo Compounds, Heterocyclic - metabolism; Chemical compounds; classification; Dermacoccus; drugs; Fundamental and applied biological sciences. Psychology; General pharmacology; genetics; Geologic Sediments; Geologic Sediments - microbiology; isolation & purification; Life Sciences; Marine sediments; Medical Microbiology; Medical sciences; metabolism; Metabolites; Microbiology; Miscellaneous; Netropsin; Netropsin - metabolism; Original Paper; Pacific Ocean; Pharmacognosy. Homeopathy. Health food; Pharmacology; Pharmacology. Drug treatments; Plant Sciences; prokaryotic cells; screening; Sea of Japan; Seawater; Seawater - microbiology; Secondary metabolites; Sediment samplers; Soil Science & Conservation; Streptomycetes; Systematics; Verrucosispora; Sea of Japan; Pacific Ocean; ISEW, Pacific, Mariana Trench, Challenger Deep; INW, Japan Sea; ISEW, Pacific, Mariana Trench; Actinobacteria; Systematics; Actinomycetes; Bioprospecting; Antibiotics; Antibiotic; Microbial origin; Taxonomy; Eubacteria; Bacteria

New structurally diverse natural products are discovered when novel screening procedures are introduced or when high quality biological materials from new sources are examined in existing screens, hence it is important to foster these two aspects of novelty in drug discovery programmes. Amongst prok...